London (PRWEB) September 24, 2013
Generics companies - assess products, developments, and revenue prospects
What does the future hold for makers of generic drugs? Visiongain's updated report shows you their prospects to 2023. There you see results, trends, opportunities, and revenue predictions.
Our study analyses 50 leading generics producers and marketers. There you find information on established and rising companies. Discover their sales potentials.
Forecasts and other data to help you stay ahead
In our new study you find analytical profiles of top companies worldwide. There you analyse historical data, market shares, revenue forecasts, and growth rates. Discover qualitative analysis too. You also gain 63 charts and 96 tables.
Our work lets you assess the most lucrative parts of the world industry for generic drugs. See now how you can benefit your research, analyses, and decisions there, also saving time.
The following sections highlight what you find in our new investigation.
Assessments of top companies - activities, results, competition, and potential sales
Our report analyses 50 manufacturers of generic medicines. In general a company profile gives you the following information:
•Discussion of a company's activities, outlook, and recent financial results
•Assessment of its developments - mergers and acquisitions (M&A), new products, and collaborations, inc. alliances, partnerships and joint ventures
•Forecasting of generic drug revenues to 2023 (for 20 of the companies).
Discover capabilities, progress, and commercial prospects, helping you stay ahead.
Now see companies you investigate there, grouped by type and geographical region.
Big pharma - generics production by the pharma industry's largest companies
First, our study gives you discussions, financial analyses, a
Copyright©2012 Vocus, Inc.
All rights reserved